For half of the biomarkers (AKT, ALK, BRAF, EGFR, Hedgehog, HER2, KRAS, MSI, NTRK, and ROS1), depending on the tumor type, the response rate ranged from 0 to 100%. This evidence concerns the gene ALK and neoplasm.